These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11027677)

  • 1. Sp3 is a transcriptional repressor of transforming growth factor-beta receptors.
    Ammanamanchi S; Brattain MG
    J Biol Chem; 2001 Feb; 276(5):3348-52. PubMed ID: 11027677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-azaC treatment enhances expression of transforming growth factor-beta receptors through down-regulation of Sp3.
    Ammanamanchi S; Brattain MG
    J Biol Chem; 2001 Aug; 276(35):32854-9. PubMed ID: 11443124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.
    Ammanamanchi S; Kim SJ; Sun LZ; Brattain MG
    J Biol Chem; 1998 Jun; 273(26):16527-34. PubMed ID: 9632722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylated sp3 is a transcriptional activator.
    Ammanamanchi S; Freeman JW; Brattain MG
    J Biol Chem; 2003 Sep; 278(37):35775-80. PubMed ID: 12837748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Sp1 in the differential expression of transforming growth factor-beta receptor type II in human breast adenocarcinoma MCF-7 cells.
    Liu Y; Zhong X; Li W; Brattain MG; Banerji SS
    J Biol Chem; 2000 Apr; 275(16):12231-6. PubMed ID: 10766860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of transforming growth factor-beta signaling through receptor RI induction by histone deacetylase activity inhibition in breast cancer cells.
    Ammanamanchi S; Brattain MG
    J Biol Chem; 2004 Jul; 279(31):32620-5. PubMed ID: 15155736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of decreased expression of transforming growth factor-beta receptor type I at late stages of HPV16-mediated transformation.
    Hypes MK; Pirisi L; Creek KE
    Cancer Lett; 2009 Sep; 282(2):177-86. PubMed ID: 19344999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.
    Periyasamy S; Ammanamanchi S; Tillekeratne MP; Brattain MG
    Oncogene; 2000 Sep; 19(40):4660-7. PubMed ID: 11030155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.
    Ko Y; Banerji SS; Liu Y; Li W; Liang J; Soule HD; Pauley RJ; Willson JK; Zborowska E; Brattain MG
    J Cell Physiol; 1998 Aug; 176(2):424-34. PubMed ID: 9648930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGF-beta 1) in articular chondrocytes involves SP3/SP1 ratio.
    Chadjichristos C; Ghayor C; Herrouin JF; Ala-Kokko L; Suske G; Pujol JP; Galéra P
    J Biol Chem; 2002 Nov; 277(46):43903-17. PubMed ID: 12186868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sp1, but not Sp3, functions to mediate promoter activation by TGF-beta through canonical Sp1 binding sites.
    Li JM; Datto MB; Shen X; Hu PP; Yu Y; Wang XF
    Nucleic Acids Res; 1998 May; 26(10):2449-56. PubMed ID: 9580699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversion of transcriptional repression of Sp1 by 5 aza-2' deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2.
    Venkatasubbarao K; Ammanamanchi S; Brattain MG; Mimari D; Freeman JW
    Cancer Res; 2001 Aug; 61(16):6239-47. PubMed ID: 11507078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased transcriptional activities of transforming growth factor beta receptors in scleroderma fibroblasts.
    Yamane K; Ihn H; Kubo M; Tamaki K
    Arthritis Rheum; 2002 Sep; 46(9):2421-8. PubMed ID: 12355490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EWS-FLI1, EWS-ERG, and EWS-ETV1 oncoproteins of Ewing tumor family all suppress transcription of transforming growth factor beta type II receptor gene.
    Im YH; Kim HT; Lee C; Poulin D; Welford S; Sorensen PH; Denny CT; Kim SJ
    Cancer Res; 2000 Mar; 60(6):1536-40. PubMed ID: 10749119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
    Jakowlew SB; Moody TW; Mariano JM
    Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel transcriptional regulation of the human CYP3A7 gene by Sp1 and Sp3 through nuclear factor kappa B-like element.
    Saito T; Takahashi Y; Hashimoto H; Kamataki T
    J Biol Chem; 2001 Oct; 276(41):38010-22. PubMed ID: 11495920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of cell-specific expression of the human cystathionine beta -synthase gene by differential binding of Sp1/Sp3 to the -1b promoter.
    Ge Y; Matherly LH; Taub JW
    J Biol Chem; 2001 Nov; 276(47):43570-9. PubMed ID: 11562358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of mouse mu opioid receptor gene: Sp3 isoforms (M1, M2) function as repressors in neuronal cells to regulate the mu opioid receptor gene.
    Choi HS; Hwang CK; Kim CS; Song KY; Law PY; Wei LN; Loh HH
    Mol Pharmacol; 2005 May; 67(5):1674-83. PubMed ID: 15703380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sp3 represses the Sp1-mediated transactivation of the human COL2A1 gene in primary and de-differentiated chondrocytes.
    Ghayor C; Chadjichristos C; Herrouin JF; Ala-Kokko L; Suske G; Pujol JP; Galera P
    J Biol Chem; 2001 Oct; 276(40):36881-95. PubMed ID: 11447232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent and distinct transcription and translation of transforming growth factor-beta type I and type II receptors in rodent embryogenesis.
    Mariano JM; Montuenga LM; Prentice MA; Cuttitta F; Jakowlew SB
    Int J Dev Biol; 1998 Nov; 42(8):1125-36. PubMed ID: 9879710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.